1. Peleg, A. Y., Seifert, H. and Paterson DL. Acinetobacter baumannii: Emergence of
a Successful Pathogen. Clin Microbiol Res. 2008;21:538–82.
2. Dey, D., Debnath, S., Hazra, S., Ghosh, S., Ray, R. and Hazra B. Pomegranate pericarp
extract enhances the antibacterial activity of ciprofloxacin against extended-spectrum
beta-lactamase (ESBL) and metallo-beta-lactamase (MBL) producing Gram-negative bacilli.
Food Chem Toxicol. 2012;50:4302–9.
3. van Looveren, M. and Goossens H. ARPAC Steering Group: Antibacterial resistance
of Acinetobacter spp. in Europe. Clin Microbiol Infect. 2004;10:684–704.
4. Navon-Venezia, S., Ben-Ami, R.and Carmeli Y. Update on Pseudomonas aeruginosa and
Acinetobacter baumannii infections in the healthcare setting. Curr Opin Infect Dis.
2005;18:306–313.
5. Nordmann, P. and Poirel L. Emerging carbapenemases in gram negative aerobes. Clin
Microbiol Infect. 2002;8:321–31.
6. Soroush, S., Haghi-Ashtiani, M.T., Taheri-Kalani, M. et al. Antimicrobial resistance
of nosocomial strain of Acinetobacter baumannii in children’s medical center of Tehran:
A 6-year prospective study. Acta Medica Iranica. 2010;48:178–184.
7. Asadollahi, P., Akbari, M., Soroush, S. et al. Antimicrobial resistance patterns
and their encoding genes among Acinetobacter baumannii strains isolated from burned
patients. Burns. 2012;38:1198–1203.
8. Amudhan, S.M., Sekar, U., Arunagiri, K. and Sekar B. OXA Beta-lactamase-mediated
carbapenem resistance in Acinetobacter baumannii. Indian J Med Microbiol. 2011;29:269–74.
9. Lin, M.F., Kuo, H.Y., Yesh, H.W., Yang, C.M., Sug, C.H. and Tu C. Emergence and
dissemination of blaOXA-23 carrying imipenem-resistant Acinetobacter spp in a regional
hospital in Taiwan. J Microbiol Immunol Infect. 2011;44:39–44.
10. Cornaglia, G., Giamarellou, H. and Rossolini G. Metallo-betalactamases: a last
frontier for beta-lactams? Lancet. Infect Dis. 2011;11:381–393.
11. Fallah, F., Hakemi, V. M., Goudarzi, H., Hashemi, A., Taherpour, A., Bigdeli,
S. K. et al. Identification of extended-spectrumbetalactamases( ESBLs), metallo-beta-lactamases
(MBLs), Amp-C and KPC ß lactamases among Klebsiella pneumoniae isolated from adults
and pediatric patients in Iran. African J Microbiol Res. 2013;7:3254–61.
12. Maragakis, L.L. and Perl T. Acinetobacter baumannii: epidemiology, antimicrobial
resistance, and treatment options. Clin Infect Dis. 2008;46:1254–63.
13. Saderi, H., Karimi, Z., Owlia, P., Bahar, A. and Akhavi RSM. Phenotypic detection
of metallobeta- lactamase-producing Pseudomonas aeruginosa strain isolated from burned
patients. Iran J Pathol. 2008;3:20–24.
14. Fiett, J. A., Baraniak, A., Mro´wka. et al. Molecular epidemiology of acquired-metallo-β
lactamase producing bacteria in Poland. Antimicrob Agents Chemothe. 2006;50:880–886.
15. Shahcheraghi, F. and Abedin M. Molecular recognition bla IMP, bla SPM, bla VIM
in Acinetobacter strains resistant to imipenem Isolated from clinical specimens. JInfect
Dis Trop Med. 2012;17:29–33.
16. Lee, K., chong, Y., Shin, H. B., Kim, Y. A., Yong, D. and Yum JH. Modified Hodge
and EDTA-disk synergy tests to screen metollo-B-lactamase-producing strains of Pseudomonas
and Acinetobacter species. Clin Microbiol Infect. 2001;7:88–102.
17. Eun-Jee, O., Seungok, L., Yeon-Joon, P., Jung, J. P., Kanggyun, P., Sang-Il, K.
et al. Prevalence of metallo-h-lactamase among Pseudomonas aeruginosa and Acinetobacter
baumannii in a Korean University hospital and comparison of screening methods for
detecting metallo-h-lactamase. J Microbiol Methods. 2003;57:411–8.
18. Upadhyay, S., Sen, M. R. and Bhattacharjee A. Presence of different betalactamase
classes among clinical isolates of Pseudomonas aeruginosa expressing AmpC beta-lactamase
enzyme. J Infect Dev Ctries. 2010;4:239–242.
19. Walsh, T. R., Bolmstrom, A., Qwarnstrom, A. and Gales A. Evaluation of a new Etest
for detecting metallo-â-lactamases in routine clinical testing. J Clin Microbiol.
2002;40:2755–9.
20. Singhal, S., Mathur, T., Khan, S., Upadhyay, D. J., Chugh, S., Gaind, R. and Rattan
A. Evaluation of methods for AmpC β-lactamase in gram negative clinical isolates from
tertiary care hospitals. Indian J Med Microbiol. 2005;23:120–4.
21. Dheepa, M. and Boppe A. Phenotypic Methods for the Detection of Various Betalactamases
in Carbapenem Resistant Isolates of Acinetobacter baumanii at a Tertiary Care Hospital
in South India. J Clin Diagn Res. 2012;6:970–3.
22. Jeong, S.H., Bae, I. K., Park, K. O., An, Y. J., Sohn, S. G., Jang, S. J. et
al. Outbreaks of imipenem-resistant Acinetobacter baumannii producing carbapenemases
in Korea. J Microbiol. 2006;44:423–3.
23. Versalovic, J., Koeuth, T. and Lupski JR. Distribution of repetitive DNA sequences
in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids
Res. 1991;19:6823–31.
24. Poirel, L., Weldhagen, G. F., Naas, T., De Champs, C., Dove, M. G. and Nordman
P. GES-2, a class A beta-lactamase from Pseudomonas aeruginosa with increased hydrolysis
of imipenem. Antimicrob Agents Chemother. 2001;45:2598–603.
25. Noori, M., Karimi, A., Fallah, F., Hashemi, A., Alimehr, S. and Goudarzi H. Aghamohammad
S. High prevalence of metallo-beta-lactamase producing Acinetobacter baumannii isolated
from two hospitals of Tehran, Iran. Arch Pediatr Infect Dis. 2014;2.
26. Peymani, A., Nahaei, M. R., Farajnia, S., Hasani, A., Mirsalehian, A., Sohrabi,
N. and Abbasi L. High Prevalence of Metallo-b-Lactamase-Producing Acinetobacter baumannii
in a Teaching Hospital in Tabriz, Iran. Jpn J Infect Dis. 2011;64:69–71.
27. Manageiro, V., Jones-Dias, D., Ferreira, E., Louro, D. and Canica M. Genetic diversity
and clonal evolution of carbapenem-resistant Acinetobacter baumannii isolates from
Portugal and the dissemination of ST118. Int J Antimicrob Agents. 2012;40:398–403.
28. Hu, Q., Hu, Z., Li, J., Tian, B. and Xu H. Detection of OXA-type carbapenemases
and integrons among carbapenem-resistant Acinetobacter baumannii in a teaching hospital
in China. J Basic Microbiol. 2011;51:467–72.
29. Kouyama, Y., Harada, S., Ishii, Y., Saga, T., Yoshizumi, A., Tateda, K. and Yamaguchi
K. Molecular characterization of carbapenem-non-susceptible Acinetobacter spp. in
Japan: predominance of multidrug-resistant Acinetobacter baumannii clonal complex
92 and IMP-type metallo-β-lactamase-producing non-baumannii Acinetobacter species.
J Infect Chem 1. 2012;18:522–8.
30. Jeon, B. C., Jeong, S. H., Bae, I. K., Kwon, S. B., Lee, K., and Young, D. et
al. Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii
producing the OXA-23 b-lactamase in Korea. J Clin Microbiol. 2005;43:2241–2245.
31. Lin, Y. C., Sheng, W. H., Chen, Y. C, Chang, S. C., Hsia, K. C. and Li SY. Differences
in carbapenem resistance genes among Acinetobacter baumannii, Acinetobacter genospecies
3 and Acinetobacter genospecies 13TU in Taiwan. Int J Antimicrob Agents. 2010;35:439–43.
32. Xiao, Y. H., Giske, C. G., Wei, Z. Q., Shen, P., Heddini, A. and Li LJ. ) Epidemiology
and characteristics of antimicrobial resistance in China. Drug Resist Updat. 2011;14:236–250.
33. Turner P. activity of meropenem and other broad-spectrum agents against nosocomial
isolates. Diagn Microbiol Infect Dis. 2009;63:217–222.
34. Sung, J. Y., Kwon, K. C, Park, J. W., Kim, Y. S., Kim, J. M., Shin, K. S., Kim,
J. W., Ko, C, S,, Shin, S. Y., Song, J. H. and Koo SH. Dissemination of IMP-1 and
OXA type β-lactamase in carbapenem-resistant Acinetobacter baumannii. Korean J Lab
Med 1. 2008;28:16–23.